Related references
Note: Only part of the references are listed.PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation
Vincenza Leone et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
The cyclooxygenase-2-mediated prostaglandin signaling is causally related to epithelial carcinogenesis
Karin Mueller-Decker et al.
MOLECULAR CARCINOGENESIS (2007)
The anti-cancer effect of COX-2 inhibitors on gastric cancer cells
Soo-Jeong Cho et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer
Li Yang et al.
CANCER RESEARCH (2007)
15-Hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer
Hsin-Hsiung Tai et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Expression of 15-hydroxyprostaglandin dehydrogenase, a COX-2 antagonist and tumour suppressor, is not altered in gastric carcinomas
Nam Jin Yoo et al.
PATHOLOGY (2007)
Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells
Aparna V. Sarthy et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The role of cyclooxygenase-2 and prostaglandins in colon cancer
Annie L. Eisinger et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
Involvement of cyclooxygenase-2-prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells
Hisashi Takehara et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells
Min Tong et al.
CARCINOGENESIS (2006)
Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer
Jun Wang et al.
CANCER LETTERS (2006)
15-Hydroxyprostaglandin-dehydrogenase is involved in anti-proliferative effect of non-steroidal anti-inflammatory drugs COX-1 inhibitors on a human medullary thyroid carcinoma cell line
Virginie Quidville et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2006)
Cellular prion protein promotes invasion and metastasis of gastric cancer
Yanglin Pan et al.
FASEB JOURNAL (2006)
15-Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis
Seung-Jae Myung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer
Ido Wolf et al.
CANCER RESEARCH (2006)
Effects of long-term rofecoxib on gastric intestinal metaplasia: Results of a randomized controlled trial
Wai K. Leung et al.
CLINICAL CANCER RESEARCH (2006)
Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression
Jason R. Mann et al.
CANCER RESEARCH (2006)
Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: A review and report of personal experience
Takashi Fujimura et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase: Structure and biological functions
HH Tai et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Lymphovascular invasion is associated with poor survival in gastric cancer - An application of gene-expression and tissue array techniques
BJ Dicken et al.
ANNALS OF SURGERY (2006)
Inhibition of gastric cancer-associated angiogenesis by antisense COX-2 transfectants
YG Fu et al.
CANCER LETTERS (2005)
15-hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer
MG Backlund et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer
YF Ding et al.
CARCINOGENESIS (2005)
Chemoprevention of gastric cancer by celecoxib in rats
PJ Hu et al.
GUT (2004)
15-hydroxyprostagland in dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers
M Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nicotine promotes gastric tumor growth and neovascularization by activating extracellular signal-regulated kinase and cyclooxygenase-2
VY Shin et al.
CARCINOGENESIS (2004)
Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines
BP van Rees et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Prostaglandin E2 increases growth and motility of colorectal carcinoma cells
HM Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
WK Leung et al.
BRITISH JOURNAL OF CANCER (2001)
Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
JJY Sung et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis
M Stolina et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
